- 199studies on this subject, of 27,780 in the library
- 180peer-reviewed
- 1990–2026years published
- 46median usefulness score out of 100
These counts and lists are worked out from the library itself each time the page loads. A score rates how much weight a study can bear — its design, journal, evidence and recency — not whether its result is good news. How we score a study. For a plain-English guide to this subject, see Costs & economics.
The 20 highest-scoring studies
- Dementia Incidence, Burden and Cost of Care: A Filipino Community-Based Study
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis
- Adjusted-Dose Warfarin versus Aspirin for Preventing Stroke in Patients with Atrial Fibrillation
- Economic Burden of Alzheimer's Disease: A Systematic Review
-
Estimating the Effect of Hospital Admission on Health Care Outcomes and Spending Among Persons With Dementia : A Quasi-experimental Study
In this analysis of Medicare beneficiaries with dementia who visited an emergency department, hospital admission was not linked to 30-day mortality or more inpatient days. Admission was linked to higher 30-day health care spending, so the findings concern costs and outcomes of hospital care rather than preventing or treating dementia.
- The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review
- Advance care planning among Medicare beneficiaries with dementia undergoing surgery
- Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis
- Association between chronic periodontitis and the risk of Alzheimer's disease: a retrospective, population-based, matched-cohort study
-
Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care: A Secondary Analysis of a Cluster Randomized Clinical Trial
In this secondary analysis of a cluster randomized clinical trial, participants receiving collaborative dementia care management showed significantly fewer behavioral and psychological symptoms, better mental health, and lower caregiver burden over 36 months. It addresses care outcomes and cost-effectiveness rather than curing or preventing Alzheimer's disease.
- Sleep apnea and the risk of dementia: a population-based 5-year follow-up study in Taiwan
- Cohort Profile: The Longitudinal Ageing Study in India (LASI)
- Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis
- Health insurance status and the care of nursing home residents with advanced dementia
- Repetitive Traumatic Brain Injury Among Older Adults
- Association of Medicare bundled payment model with joint replacement care for people with dementia
- Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus
-
Cost-utility of a new psychosocial goal-setting and manualised support intervention for independence in dementia (NIDUS-Family) versus goal setting and routine care: an economic evaluation embedded within a randomised controlled trial
In this economic evaluation within a randomized controlled trial of 302 people with dementia and their family carers, there was an 89% probability that NIDUS-Family was cost-effective compared with usual care from a health and social care perspective at both £20,000 and £30,000 decision thresholds, and an 87% probability from a societal perspective. It addresses cost-effectiveness of a psychosocial and behavioural intervention for goal attainment, not a cure or prevention of Alzheimer's disease.
- Cost of dementia in Medicare managed care: a systematic literature review
See all 199 studies in Costs and economics, with filters →
Newest additions on this subject
- How Much Non-response Matters? Diagnosis Prevalence Estimates in Survey Participants Versus the Total Sample
- Variation in Medicare Part D and Part B drug spending among older adults with Alzheimer's disease and related dementias
- Death in People with Down syndrome: Mortality statistics and novel predictors in US Medicaid and Medicare enrolled adults
- Chart review and genetic validation of electronic medical record dementia diagnoses in VA: The impact of CMS data
- The cost of dementia in the United States in 2026
- Prevalence of epilepsy and young-onset dementia in adults with intellectual disability: Contrasting Down syndrome and autism diagnoses
- Dementia and Frailty Impact Postoperative Care Trajectories and Burden among Older Adults Undergoing Radical Cystectomy for Bladder Cancer
- Cost utility and cost-effectiveness of the APPLE-Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce: economic evaluation embedded within a randomised controlled trial
- Mapping U.S. POINTER Cognitive-Slope Gains Onto Predicted Clinical Progression: An External-Cohort Translation Analysis With Exploratory Economic Thresholds
- The social value of lecanemab for patients with early Alzheimer's disease in Japan
All 199 studies in Costs and economics, newest first →
From across this subject
9 of the 199 studies in this subject, picked by a fixed rule (a hash of each study's address), not by score or date. The same 9 appear here every time.
- Medical and nursing home costs: From cognitively unimpaired through dementia
- Savings and outcomes under Medicare's bundled payments initiative for skilled nursing facilities
- Clinical and public health implications of periodontal and systemic diseases: An overview
- Economic Burden of Alzheimer's Disease Dementia in Japan
- Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study
- What is the current state of care for older people with dementia in general hospitals? A literature review
- Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer Disease
- Epidemiology and economic burden of Lewy body dementia in the United States
- Cost-utility analysis of the DREAMS START intervention for people living with dementia and their carers: a within-trial economic evaluation
What the library holds on this subject
By review status
| Status | Studies |
|---|---|
| Peer-reviewed | 180 |
| Preprint — not yet peer-reviewed | 14 |
| Report — not peer-reviewed | 5 |
By strength of evidence
| Rated in our summary | Studies |
|---|---|
| low | 100 |
| moderate | 69 |
| high | 23 |
| early | 4 |
| preliminary | 2 |
| not rated | 1 |
Most frequent journals
| Journal | Studies |
|---|---|
| Journal of the American Geriatrics Society | 15 |
| medRxiv | 10 |
| Alzheimer's & dementia : the journal of the Alzheimer's Association | 9 |
| Journal of Alzheimer's disease : JAD | 6 |
| Neurology | 6 |
| Health Technology Assessment | 4 |
| Journal of Alzheimer's Disease | 4 |
| The journals of gerontology. Series A, Biological sciences and medical sciences | 4 |
| Aging & mental health | 3 |
| Alzheimer's & Dementia | 3 |
Studies by year published
| Year | Studies | Bar |
|---|---|---|
| 2026 | 26 | |
| 2025 | 16 | |
| 2024 | 16 | |
| 2023 | 9 | |
| 2022 | 15 | |
| 2021 | 12 | |
| 2020 | 9 | |
| 2019 | 13 | |
| 2018 | 5 | |
| 2017 | 9 | |
| 2016 | 5 | |
| 2015 | 4 | |
| 2014 | 9 | |
| 2013 | 8 | |
| 2012 | 5 | |
| 2011 | 3 | |
| 2010 | 2 | |
| 2009 | 2 | |
| 2008 | 4 | |
| 2007 | 5 | |
| 2006 | 4 | |
| 2005 | 2 | |
| 2004 | 3 | |
| 2003 | 2 | |
| 2002 | 2 | |
| 2001 | 2 | |
| 2000 | 1 | |
| 1999 | 1 | |
| 1998 | 1 | |
| 1996 | 2 | |
| 1991 | 1 | |
| 1990 | 1 |
Counts the 199 studies with a usable publication date. The library is a large sample of published work, not a complete index, so these counts describe the library, not the whole field.
Other subjects in the library
- Getting a diagnosis
- Biomarkers
- Clinical trials
- Prevention and risk
- Caregiving
- How common it is
- Genetics
- Laboratory science
- Disease mechanisms
- Vascular contributions
- Prevention trials
- Clinical safety
- Health systems and care delivery
- End-of-life care
- Risk factors
- Digital health tools
- Treatments
- Disparities
- Mild cognitive impairment
- Risk genes beyond APOE
- Brain scans and imaging
- TREM2 and immune genetics
- Cognitive tests and assessment
- Lewy body dementia
- Down syndrome and Alzheimer's
- Long-term cohort studies
- Inflammation and the immune system
- Tau biomarkers
- Brain tissue and pathology
- Drug development
- Hippocampus size on brain scans